Regeneron Pharmaceuticals target price raised by Leerink Partners to $997 from $835
REGN•Leerink Partners raised its target price for Regeneron Pharmaceuticals to $997 from $835.
Related News
Estee Lauder lifts annual targets as luxury fragrance drives sales ahead of holidays
EL•
Marvell to buy Lumentum in $115 billion deal in AI data-center bet
LITE•
First Industrial Realty Trust: Wells Fargo cuts target price to $60 from $66
FR•
Universal Health Services target price raised to $170 from $166
UHS•
Alliant Energy target price raised to $82 from $81
LNT•